Osteoarthritis: Bone as an imaging biomarker and treatment target in OA
- PMID: 27383914
- PMCID: PMC4995125
- DOI: 10.1038/nrrheum.2016.113
Osteoarthritis: Bone as an imaging biomarker and treatment target in OA
Abstract
Radiographic joint-space width is the standard structural outcome for trials in knee osteoarthritis (OA), but MRI provides comprehensive 3D insights into the multi-tissue pathology of OA and could provide a superior means of monitoring disease progression and response to treatment. A new study highlights bone as an imaging biomarker.
Conflict of interest statement
statement The authors declare no competing interests.
Figures
Comment on
-
The relationship between three-dimensional knee MRI bone shape and total knee replacement-a case control study: data from the Osteoarthritis Initiative.Rheumatology (Oxford). 2016 Sep;55(9):1585-93. doi: 10.1093/rheumatology/kew191. Epub 2016 May 15. Rheumatology (Oxford). 2016. PMID: 27185958 Free PMC article.
References
-
- Hunter D, et al. Longitudinal validation of periarticular bone area and 3D shape as biomarkers for knee OA progression? Data from the FNIH OA Biomarkers Consortium. Ann Rheum Dis. 2015 http://dx.doi.org/10.1136/annrheumdis-2015-207602. - DOI - PubMed
-
- Neogi T, Conaghan PG, Niu J, Zhang Y, Bowes M. Trajectories of MRI-based 3-dimensional bone shape of the knee over 6 years: insights into knee osteoarthritis progression. Osteoarthritis Cartilage. 2016;24(Suppl. 1):S57.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
